AMA
Kałużny JJ, Szaflik J, Czechowicz-Janicka K, et al. Timolol 0,5%/ dorzolamide 2% fixed combination
versus timolol 0,5%/ pilocarpine 2%
fixed combination in primary
open-angle glaucoma or ocular
hypertensive patients. Klinika Oczna / Acta Ophthalmologica Polonica Supplement. 2004:241-242.
APA
Kałużny, J. J., Szaflik, J., Czechowicz-Janicka, K., Kałużny, J., Orzałkiewicz, A., & Zaleska-Żmijewska, A. et al. (2004). Timolol 0,5%/ dorzolamide 2% fixed combination
versus timolol 0,5%/ pilocarpine 2%
fixed combination in primary
open-angle glaucoma or ocular
hypertensive patients. Klinika Oczna / Acta Ophthalmologica Polonica Supplement, 241-242.
Chicago
Kałużny, Jakub J, Jerzy Szaflik, Krystyna Czechowicz-Janicka, Józef Kałużny, Alicja Orzałkiewicz, Anna Zaleska-Żmijewska, and Małgorzata Krajewska et al. 2004. "Timolol 0,5%/ dorzolamide 2% fixed combination
versus timolol 0,5%/ pilocarpine 2%
fixed combination in primary
open-angle glaucoma or ocular
hypertensive patients". Klinika Oczna / Acta Ophthalmologica Polonica Supplement: 241-242.
Harvard
Kałużny, J., Szaflik, J., Czechowicz-Janicka, K., Kałużny, J., Orzałkiewicz, A., Zaleska-Żmijewska, A., Krajewska, M., Stewar, J., Leech, J., and Stewar, W. (2004). Timolol 0,5%/ dorzolamide 2% fixed combination
versus timolol 0,5%/ pilocarpine 2%
fixed combination in primary
open-angle glaucoma or ocular
hypertensive patients. Klinika Oczna / Acta Ophthalmologica Polonica Supplement, pp.241-242.
MLA
Kałużny, Jakub et al. "Timolol 0,5%/ dorzolamide 2% fixed combination
versus timolol 0,5%/ pilocarpine 2%
fixed combination in primary
open-angle glaucoma or ocular
hypertensive patients." Klinika Oczna / Acta Ophthalmologica Polonica Supplement, 2004, pp. 241-242.
Vancouver
Kałużny J, Szaflik J, Czechowicz-Janicka K, Kałużny J, Orzałkiewicz A, Zaleska-Żmijewska A et al. Timolol 0,5%/ dorzolamide 2% fixed combination
versus timolol 0,5%/ pilocarpine 2%
fixed combination in primary
open-angle glaucoma or ocular
hypertensive patients. Klinika Oczna / Acta Ophthalmologica Polonica Supplement. 2004:241-242.